Q4 2015 13F Holders as of 31 Dec 2015
-
Type / Class
-
Equity / Common Stock, $0.00000002 par value
-
Shares outstanding
-
29,545,622
-
Total 13F shares
-
6,600,579
-
Share change
-
+366,626
-
Total reported value
-
$10,561,000
-
Put/Call ratio
-
105%
-
Price per share
-
$1.60
-
Number of holders
-
37
-
Value change
-
+$592,486
-
Number of buys
-
20
-
Number of sells
-
14
Institutional Holders of MEI Pharma, Inc. - Common Stock, $0.00000002 par value (MEIP) as of Q4 2015
As of 31 Dec 2015,
MEI Pharma, Inc. - Common Stock, $0.00000002 par value (MEIP) was held by
37 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
6,600,579 shares.
The largest 10 holders included
Frigate Ventures LP, VANGUARD GROUP INC, Ancora Advisors, LLC, BlackRock Institutional Trust Company, N.A., Connor, Clark & Lunn Investment Management Ltd., BRIDGEWAY CAPITAL MANAGEMENT INC, FMR LLC, RENAISSANCE TECHNOLOGIES LLC, WASATCH ADVISORS INC, and SABBY MANAGEMENT, LLC.
This page lists
37
institutional shareholders reporting positions in this security
for the Q4 2015 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.